(Q39569395)

13 September 2017

title

Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer (English)

1 reference

adaptive radiation therapy

13 September 2017

main subject

0 references

4

Hirokazu Nagawa

1 reference

13 September 2017

Koji Yasuda

1

1 reference

13 September 2017

Takako Nirei

series ordinal

2

1 reference

13 September 2017

Nelson Hirokazu Tsuno

series ordinal

3

1 reference

13 September 2017

Joji Kitayama

series ordinal

5

1 reference

13 September 2017

publication date

27 April 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

102

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

1257-1263

1 reference

Preoperative versus postoperative chemoradiotherapy for rectal cancer

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Chemotherapy with preoperative radiotherapy in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

The role of p53 in determining sensitivity to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Radiation-induced bystander effects--implications for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

New insights on cell death from radiation exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Radiation and the microenvironment - tumorigenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Systemic effects of local radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Sensors of ionizing radiation effects on the immunological microenvironment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Abscopal effect of radiation in papillary adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Immune modulation by ionizing radiation and its implications for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Standard treatments induce antigen-specific immune responses in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

T-cell responses to survivin in cancer patients undergoing radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Radiation-enhanced immune response to cancer: workshop, Anaheim, CA, April 17, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01940.X

10.1111/J.1349-7006.2011.01940.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference